The Effectiveness of Combined Lipid-Lowering Therapy in Patients after Coronary Artery Revascularization

For the study were selected 64 patients suffering from coronary artery disease Acute myocardial infarction, who were directed to revascularization of the coronary arteries with stenting. Two groups were identified by random sampling. The first group consisted of 32 patients who received hypolipidemicmonotherapy (20 mg rosuvostatin) at the hospital and post-hospital stages, the remaining 32 patients that made up the second group received combined hypolipidemic therapy (20 mg rosuvostatin + 10 mg ezetimibe) at the hospital and post-hospital stages. All patients underwent ECG, the whole complex of clinical and biochemical examinations including the lipid spectrum of blood after 10 and 30 days of treatment, echocardiography, coronary angiography. As a result of the research, it was revealed that combined lipid-lowering therapy had a positive effect on the dynamics of patients with coronary artery disease after coronary artery stenting.